Jiří Voller

Jiří Voller

Auto-generated profile, based on publicly available information

Jiří Voller

Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University , Olomouc, 77900

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Ageing Research Reviews
Verified
Journal Article
Closed access
AKAlena Kadlecová
Alena Kadlecová
BMBarbara Maková
Barbara Maková
MSMarta Artal Sanz
Marta Artal Sanz
MSMiroslav Strnad
Miroslav Strnad
JVJiří Voller
Jiří Voller

17 June 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
SJSushovan Jena
Sushovan Jena
GGGabriel Gonzalez
Gabriel Gonzalez
DVDominik Vítek
Dominik Vítek
MKMarie Kvasnicová
Marie Kvasnicová
ŠŠŠárka Štěpánková
Šárka Štěpánková
KCKaushik Chanda
Kaushik Chanda
A novel group of 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines was prepared via a microwave assisted one-pot telescopic approach. The synthetic sequence involves the formation of an amine precursor of imidazo [1,2-a]pyridine via condensation and reduction under microwave irradiation. Subsequently, the Pictet-Spengler cyclisation reaction occurs with ketones (cyclic or acyclic) to obtain substituted 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines in excellent yields. The compounds were tested as neuroprotective agents. Observed protection of neuron-like cells, SH-SY5Y differentiated with ATRA, in Parkinson's and Huntington's disease models inspired further mechanistic studies of protective activity against damage induced by 1-methyl-4-phenylpyridinium (MPP+), a compound causing Parkinson's disease. The novel compounds exhibit similar or higher potency than ebselen, an established drug with antioxidant activity, in the cells against MPP + -induced total cellular superoxide production and cell death. However, they exhibit a significantly higher capacity to reduce mitochondrial superoxide and preserve mitochondrial membrane potential. We also observed marked differences between a selected derivative and ebselen in terms of normalizing MPP + -induced phosphorylation of Akt and ERK1/2. The cytoprotective activity was abrogated when signaling through cannabinoid receptor CB2 was blocked. The compounds also inhibit both acetylcholine and butyrylcholine esterases. Overall the data show that novel 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinoline have a broad cytoprotective activity which is mediated by several mechanisms including mitoprotection.

11 November 2019 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
VMVaida Milišiūnaitė
Vaida Milišiūnaitė
AKAlena Kadlecová
Alena Kadlecová
AŽAsta Žukauskaitė
Asta Žukauskaitė
Karel DolezalKarel Dolezal
Karel Dolezal
MSMiroslav Strnad
Miroslav Strnad
AŠAlgirdas Šačkus
Algirdas Šačkus

22 August 2017
Verified
Book Chapter
Closed access
PDF file
JVJiří Voller
Jiří Voller
BMBarbara Maková
Barbara Maková
AKAlena Kadlecová
Alena Kadlecová
GGGabriel Gonzalez
Gabriel Gonzalez
MSMiroslav Strnad
Miroslav Strnad

18 December 2017 in Biogerontology
Verified
Journal Article
Closed access
PDF file
AKAlena Kadlecová
Alena Kadlecová
TJTomáš Jirsa
Tomáš Jirsa
Ondrej NovakOndrej Novak
Ondrej Novak
JKJan Kammenga
Jan Kammenga
MSMiroslav Strnad
Miroslav Strnad
JVJiří Voller
Jiří Voller

4 July 2019 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
JVJiří Voller
Jiří Voller
TBTibor Béres
Tibor Béres
MZMarek Zatloukal
Marek Zatloukal
PDPetr Džubák
Petr Džubák
MHMarián Hajdúch
Marián Hajdúch
MSMiroslav Strnad
Miroslav Strnad